Cargando…

Cumulative clinical experience from over a decade of use of levofloxacin in urinary tract infections: critical appraisal and role in therapy

The treatment of urinary tract infections (UTIs) continues to evolve as common uropathogens increasingly become resistant to previously active antimicrobial agents. In addition, bacterial isolates, which were once considered to be either colonizers or contaminants, have emerged as true pathogens, li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bush, Larry M, Chaparro-Rojas, Fredy, Okeh, Victor, Etienne, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215342/ https://www.ncbi.nlm.nih.gov/pubmed/22114510 http://dx.doi.org/10.2147/IDR.S15610

Ejemplares similares

Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
por: Noreddin, Ayman M, et al.
Publicado: (2011)

Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis
por: McGregor, Jessina C, et al.
Publicado: (2008)

Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections
por: Armstrong, Eliana S., et al.
Publicado: (2016)

Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis
por: Cao, Dehong, et al.
Publicado: (2021)

Prevalence of and Risk Factors for Levofloxacin-Resistant E. coli Isolated from Outpatients with Urinary Tract Infection
por: Jang, Woo Hyuk, et al.
Publicado: (2011)

Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
por: Uy, J, et al.
Publicado: (2012)

1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the ASPECT-cUTI Trial
por: Sakoulas, George, et al.
Publicado: (2014)

Febrile urinary tract infection in children: changes in epidemiology, etiology, and antibiotic resistance patterns over a decade
por: Suh, Woosuck, et al.
Publicado: (2020)

Role of urodynamics in stress urinary incontinence: A critical appraisal
por: Yande, Shirish Dattatraya, et al.
Publicado: (2016)

In vitro activity of levofloxacin against lower respiratory tract pathogens
por: Sarkar, Soma, et al.
Publicado: (2015)

A Critical Appraisal of Methods for Disruption and Extraction of Urinary Calculi, Especially with Ultrasound
por: Lamport, Harold, et al.
Publicado: (1955)

Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal
por: García-Carmona, Juan Antonio, et al.
Publicado: (2023)

Cumulative Incidence of Infective Endocarditis in Patients with Congenital Heart Disease: A Nationwide, Case-Control Study Over Nine Decades
por: Snygg-Martin, Ulrika, et al.
Publicado: (2021)

Critical Appraisal --- The Response
por: Garg, Ritesh, et al.
Publicado: (2018)

Critical appraisal of the literature
por: FERREIRA, ÁLIDA ROSÁRIA SILVA, et al.
Publicado: (2021)

Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial
por: Ren, Hong, et al.
Publicado: (2017)

The change of antibiotic susceptibility in febrile urinary tract infection in childhood and adolescence during the last decade
por: Choi, Useok, et al.
Publicado: (2022)

Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration
por: Wada, Takeshi, et al.
Publicado: (2015)

A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
por: Connolly, Lynn E., et al.
Publicado: (2018)

Clinical significance of urinary obstruction in critically ill patients with urinary tract infections
por: Hong, Jun Young, et al.
Publicado: (2020)

Critical appraisal of clinical practice guidelines for treatment of urinary incontinence: Protocol for a systematic review
por: Smiles, Flavia Blaseck, et al.
Publicado: (2019)

Quality appraisal of clinical guidelines for recurrent urinary tract infections using AGREE II: a systematic review
por: Pat, Jorik J., et al.
Publicado: (2022)

Appraising epidemiology data and antimicrobial resistance of urinary tract infections in critically ill adult patients: a 7-year retrospective study in a referral Brazilian hospital
por: de Almeida, Vitelhe Ferreira, et al.
Publicado: (2023)

Not so critical appraisal of dapagliflozin
por: Doggrell, Sheila A
Publicado: (2014)

Critical appraisal of Doshavaha Srotas
por: Byadgi, Parameswarappa S.
Publicado: (2012)

Critical appraisal of published literature
por: Umesh, Goneppanavar, et al.
Publicado: (2016)

Minipolymyoclonus: A Critical Appraisal
por: Ganguly, Jacky, et al.
Publicado: (2021)

Levofloxacin-induced acute psychosis
por: Moorthy, Nagaraja, et al.
Publicado: (2008)

Acute Delirium Associated With Levofloxacin
por: Kogan, Yana, et al.
Publicado: (2018)

Levofloxacin-Induced Myoclonus and Encephalopathy
por: Reddy, V. Abhinay S. K., et al.
Publicado: (2020)

Levofloxacin-Induced Acute Pancreatitis
por: Neto Gonçalves, Tiago, et al.
Publicado: (2021)

Hepatotoxicity Secondary to Levofloxacin Use
por: Panahi, Ladan, et al.
Publicado: (2021)

Levofloxacin-Associated Neurotoxicity in a Patient with a High Concentration of Levofloxacin in the Blood and Cerebrospinal Fluid
por: Nishikubo, Masashi, et al.
Publicado: (2019)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

Candida auris Urinary Tract Infections and Possible Treatment
por: Griffith, Nicole, et al.
Publicado: (2020)

Critical appraisal of clinical practice guidelines for treatment of urinary incontinence: Protocol for a systematic review: Erratum
Publicado: (2019)

Emerging therapies for Clostridium difficile infection – focus on fidaxomicin
por: Chaparro-Rojas, Fredy, et al.
Publicado: (2013)

Efficacy of levofloxacin against biofilms of Pseudomonas aeruginosa isolated from patients with respiratory tract infections in vitro
por: She, Pengfei, et al.
Publicado: (2018)

Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections
por: Dalhoff, A., et al.
Publicado: (2017)

A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection
por: Li, Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_340msgt589harjinfs947il8rp